Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

Biden Discusses More Details on Cancer Moonshot Initiative

By Drug Discovery Trends Editor | January 20, 2016

Drop of Light/ Shutterstock.comVice President Joe Biden revealed more information today regarding the plan to cure cancer he was placed in charge of during last week’s State of the Union.

He called for quicker drug approvals during a panel at this year’s World Economic Forum in Davos, Switzerland. Part of the initiative would involve expediting the process of bringing new types of immunotherapies to market, reports Reuters.

Biden told the audience he recently met with the head of the Food and Drug Administration (FDA) and three unnamed drug companies at his home to discuss the plan, in which both sides agreed to do more to help patients receive potent therapies.

Immunotherapies have shown significant promise in using the human body’s natural defenses to fend off cancer, but Reuters explains that these drugs can be very expensive (reaching up to $100,000 a year per patient) while pharmaceutical firms have been reticent in divulging information on early-stage medical experiments.

READ MORE: Biden Reveals Details on Cancer Moonshot Project

The Vice President called for cancer researchers to help “learn what it would take to make major progress” on beating the disease so he can better educate the public about what steps need to be taken, according to Stat News.

He told the crowd “My job…is to educate the public in very simple language why I’m going to ask so much more of them — a lot more money, a lot more tax dollars, a lot more cooperation.”

Data sharing will be a core component of this program, too. Biden is seeking a way to build a data infrastructure to enable better sharing of medical information, but it was acknowledged during the panel that privacy concerns could be an impediment, writes Stat News.

Biden has made finding a cure for cancer his personal mission after losing his son Beau to a brain tumor last year.

Cancer researchers have expressed concerns that this strategy is presenting an “over-simplified” solution for a complex problem. It would take more than one designated “cure” to eliminate all forms of this condition, they say. 


Filed Under: Drug Discovery

 

Related Articles Read More >

Sai Life Sciences exec: GLP-1 boom has ‘exploded the peptide field’ as firm opens new center
Novartis in the Pharma 50
Swissmedic approves first malaria treatment for infants
Korean team reports all-in-one cancer nanomedicine in pre-clinical studies
Nektar’s Phase 2b atopic dermatitis win triggers 1,746% analyst target surge, but legal tussle with ex-partner Lilly could complicate path forward
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE